Clinical relevance of tumour markers in head and neck squamous cell cancer;Stellenwert von Tumormarkern bei primaren und rezidivierenden Plattenepithelkarzinomen des Kopf-Hals-Bereiches

Tumor Diagnostik und Therapie

Volumn 17, Issue 4, 1996, Pages 116-121

  Stieber, Petra ^a,b   Wollenberg, B ^b   Schmitt, U M ^a   Von Jan, N ^b   Hofmann, K ^a   Fateh Moghadam, A ^a  

^a Institut Für Klinische Chemie   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

CEA; CYFRA 21 1; cytokeratin 19; SCC; squamous cell carcinoma of the head and neck (SCCHN); tumour marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; SMOKING;

EID: 0029746646     PISSN: 0722219X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Clasen B, Pere P, Senekowitsch R, Menz E: Das Plattenepithelkarzinomassoziierte Antigen (SCC) als Tumormarker bei der Initialdiagnostik von Karzinomen des Kopf-Hals-Gebietes. Laryngo-Rhino-Otol. 69 (1990) 275-280
2. Dienemann H, Stieber P, Zimmermann A, Hofmann H, Müller C, Banauch D: Tumor marker CYFRA 21-1 in non small cell lung cancer (NSCLC). Role for detection of recurrence. Lung cancer (1994) 11, Suppl. No 1:46
3. Fateh-Moghadam A, Stieber P: Sensible use of tumour markers. Jürgen Hartmann Verlag, Marloffstein, 2nd edition (1993)
4. Fischbach W, Meyer T, Barthel K: Squamous cell carcinoma antigen in the diagnosis and treatment follow-up of oral and facial squamous cell carcinoma Cancer, 65 (1989) 1321-1324
5. Grosskopf J: Dissertation: Der Stellenwert des Tumormarkers SCC bei der Diagnose, Verlaufsbeobachtung und Therapieeffizienzkontrolle von malignen Tumoren des HNO-Traktes. Ludwig Maximilians Universität München 1993
6. Kato H, Torigoe T: Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma Cancer, 40 (1977) 1621-1628
7. Kato H, Tamai K, Moriok A H, Nagaya T, Torigoe T: tumor antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma. Cancer 54 (1984) 1544-1546
8. Lüthgens M, Schlegel G: Kopf-Hals-Malignom. In: Tumormarker-system CEA-TPA, TumorDiagnostik Verlag, Leonberg (1987) 193-200
9. Rassekh C H, Johnson J T, Eibling D E: Circulating markers in squamous cell carcinoma of the head and neck Oral Oncol, Eur. J. Cancer, 30B (1994) 23-28
10. Silverman N A, Alexander J C, Chretien P B: CEA levels in head and neck cancer Cancer, 37 (1976) 2204-2211
11. Snydermann C H, Damico F, Wagner R, Eibling D E: A reappraisel of the squamous cell carcinoma antigen as a tumor marker in head and neck cancer. Arch. Otorhinolaryngol. Head Neck Surg. 121 (1995) 1294-1297
12. Staab H J: Medizinisch biologische Bedeutung des carcinoembryonalen Antigens (CEA). Editiones "Roche", Basel (1984)
13. Stieber P, Grosskopf J, Behbehani A, Fateh-Moghadam A: Significance of SCC and CEA in diagnosis and follow-up care of ENT-squamous cell carcinomas. In: Tumour associated antigens, oncogenes, receptors, cytokines in tumour diagnosis and therapy in the beginning of the 90th. Hrsg. Klapdor R, Zuckschwerdt Verlag München (1992) 3-6
14. Stieber P, Hasholzner U: CYFRA 21-1: A new marker in lung cancer. Cancer, 72/3 (1993) 707-713
15. Walther E K, Dahlmann N, Gorgulla H T: Tumormarker bei Patienten mit Kopf-Hals-Karzinomen. Laryngo-Rhino-Otol. 69 (1990) 271-274